rs137852820

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001367721.1(CASK):​c.1186C>T​(p.Pro396Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000582 in 1,202,665 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P396A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.000041 ( 0 hom. 15 hem. )

Consequence

CASK
NM_001367721.1 missense

Scores

2
3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:5

Conservation

PhyloP100: 9.60

Publications

11 publications found
Variant links:
Genes affected
CASK (HGNC:1497): (calcium/calmodulin dependent serine protein kinase) This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
CASK Gene-Disease associations (from GenCC):
  • FG syndrome 4
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • syndromic X-linked intellectual disability Najm type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12711546).
BP6
Variant X-41589562-G-A is Benign according to our data. Variant chrX-41589562-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 11536.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000223 (25/112279) while in subpopulation AFR AF = 0.000809 (25/30900). AF 95% confidence interval is 0.000562. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High AC in GnomAd4 at 25 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASKNM_001367721.1 linkc.1186C>T p.Pro396Ser missense_variant Exon 13 of 27 ENST00000378163.7 NP_001354650.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASKENST00000378163.7 linkc.1186C>T p.Pro396Ser missense_variant Exon 13 of 27 5 NM_001367721.1 ENSP00000367405.1

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
25
AN:
112279
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000809
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000602
AC:
11
AN:
182614
AF XY:
0.0000447
show subpopulations
Gnomad AFR exome
AF:
0.000685
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000413
AC:
45
AN:
1090386
Hom.:
0
Cov.:
26
AF XY:
0.0000421
AC XY:
15
AN XY:
356230
show subpopulations
African (AFR)
AF:
0.00122
AC:
32
AN:
26262
American (AMR)
AF:
0.00
AC:
0
AN:
35187
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19335
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30125
South Asian (SAS)
AF:
0.0000742
AC:
4
AN:
53890
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40480
Middle Eastern (MID)
AF:
0.000503
AC:
2
AN:
3978
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
835290
Other (OTH)
AF:
0.000153
AC:
7
AN:
45839
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000223
AC:
25
AN:
112279
Hom.:
0
Cov.:
23
AF XY:
0.000261
AC XY:
9
AN XY:
34455
show subpopulations
African (AFR)
AF:
0.000809
AC:
25
AN:
30900
American (AMR)
AF:
0.00
AC:
0
AN:
10563
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3621
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6090
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53292
Other (OTH)
AF:
0.00
AC:
0
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000443
Hom.:
3
Bravo
AF:
0.000257
ESP6500AA
AF:
0.000782
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000412
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CASK: BS2 -

Jun 07, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 19377476, 23871722, 33090494, 24505460, 21954287, 22452838, 19847910, 21735175, 29426960, 25886057, 20029458) -

FG syndrome 4 Pathogenic:1
May 01, 2009
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Inborn genetic diseases Benign:1
Jan 24, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Syndromic X-linked intellectual disability Najm type Benign:1
May 06, 2020
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, that leads to the substitution of proline in codon 396 for serine, has been previously reported in medical literature to segregate with the phenotype of X-linked intellectual deficiency in one family (PMID: 19377476). However, functional studies demonstrate that it results in a structurally stable protein and interactions with liprin-α, Mint-1 and Veli are preserved (PMID: 24505460). In addition, it is observed at a higher than expected frequency in population databases, including 5 hemizygous individuals (gnomAD v2.1.1). Therefore, this variant was considered to be likely benign. -

Intellectual disability, CASK-related, X-linked Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
24
DANN
Benign
0.91
DEOGEN2
Benign
0.31
.;.;.;.;.;.;.;T;.;.;.;.;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
-0.34
.;N;.;N;.;.;.;N;.;.;.;N;.;.
PhyloP100
9.6
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-2.2
.;N;.;.;.;N;.;N;.;.;.;N;.;.
REVEL
Uncertain
0.29
Sift
Benign
0.37
.;T;.;.;.;T;.;T;.;.;.;T;.;.
Sift4G
Benign
0.81
.;.;.;.;.;T;.;T;.;.;.;T;.;.
Polyphen
0.0010
B;D;.;B;.;.;.;B;.;.;.;.;.;.
Vest4
0.20, 0.44
MVP
0.88
MPC
1.1
ClinPred
0.15
T
GERP RS
5.8
Varity_R
0.11
gMVP
0.69
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852820; hg19: chrX-41448815; API